These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8410484)

  • 1. Advanced glycosylation end products: a new disease marker for diabetes and aging.
    Wu JT
    J Clin Lab Anal; 1993; 7(5):252-5. PubMed ID: 8410484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of diabetes: identification of markers for early detection, glycemic control, and monitoring clinical complications.
    Wu JT
    J Clin Lab Anal; 1993; 7(5):293-300. PubMed ID: 8410489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proteins modified in the nonenzymatically glycosylation reaction (AGE-proteins)--new markers for diabetes?].
    Zdrojewicz Z; Januszewski A; Kwiatkowska D
    Postepy Hig Med Dosw; 1994; 48(6):689-700. PubMed ID: 7675730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review.
    Fishman SL; Sonmez H; Basman C; Singh V; Poretsky L
    Mol Med; 2018 Nov; 24(1):59. PubMed ID: 30470170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobin-AGE: a circulating marker of advanced glycosylation.
    Makita Z; Vlassara H; Rayfield E; Cartwright K; Friedman E; Rodby R; Cerami A; Bucala R
    Science; 1992 Oct; 258(5082):651-3. PubMed ID: 1411574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end-products: Mechanics of aged collagen from molecule to tissue.
    Gautieri A; Passini FS; Silván U; Guizar-Sicairos M; Carimati G; Volpi P; Moretti M; Schoenhuber H; Redaelli A; Berli M; Snedeker JG
    Matrix Biol; 2017 May; 59():95-108. PubMed ID: 27616134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-enzymatic glycation of proteins: from diabetes to cancer].
    Ansari NA; Rasheed Z
    Biomed Khim; 2010; 56(2):168-78. PubMed ID: 21341505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end-products: a review.
    Singh R; Barden A; Mori T; Beilin L
    Diabetologia; 2001 Feb; 44(2):129-46. PubMed ID: 11270668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of mass spectrometry in studies of glycation processes and diabetes management.
    D'Aronco S; Crotti S; Agostini M; Traldi P; Chilelli NC; Lapolla A
    Mass Spectrom Rev; 2019 Jan; 38(1):112-146. PubMed ID: 30423209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemical properties and clinical significance of protein glycation products].
    Staniszewska M; Gamian A
    Postepy Hig Med Dosw; 2003; 57(2):123-47. PubMed ID: 12866352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonenzymatic glycation of collagen in aging and diabetes.
    Reiser KM
    Proc Soc Exp Biol Med; 1991 Jan; 196(1):17-29. PubMed ID: 1984239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid glycation and protein glycation in diabetes and atherosclerosis.
    Miyazawa T; Nakagawa K; Shimasaki S; Nagai R
    Amino Acids; 2012 Apr; 42(4):1163-70. PubMed ID: 20957396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-enzymatic glycation of proteins: a cause for complications in diabetes.
    Nawale RB; Mourya VK; Bhise SB
    Indian J Biochem Biophys; 2006 Dec; 43(6):337-44. PubMed ID: 17285797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycated lysine residues: a marker for non-enzymatic protein glycation in age-related diseases.
    Ansari NA; Moinuddin ; Ali R
    Dis Markers; 2011; 30(6):317-24. PubMed ID: 21725160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glycation and protein crosslinking in the diabetes and ageing pathogenesis].
    Cárdenas-León M; Díaz-Díaz E; Argüelles-Medina R; Sánchez-Canales P; Díaz-Sánchez V; Larrea F
    Rev Invest Clin; 2009; 61(6):505-20. PubMed ID: 20184132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycosylation end products in continuous ambulatory peritoneal dialysis patients.
    Korbet SM; Makita Z; Firanek CA; Vlassara H
    Am J Kidney Dis; 1993 Oct; 22(4):588-91. PubMed ID: 8213800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry of advanced glycation end products.
    Lapolla A; Basso E; Traldi P
    Adv Clin Chem; 2005; 40():165-217. PubMed ID: 16355923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation end-products and the progress of diabetic vascular complications.
    Jakus V; Rietbrock N
    Physiol Res; 2004; 53(2):131-42. PubMed ID: 15046548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential clinical utility of advanced glycation end product cross-link breakers in age- and diabetes-associated disorders.
    Yamagishi S
    Rejuvenation Res; 2012 Dec; 15(6):564-72. PubMed ID: 22950433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of advanced glycosylation end products in the kidney and liver from spontaneously diabetic Chinese hamsters determined by immunochemical assay.
    Abiko A; Eto M; Makino I; Araki N; Horiuchi S
    Metabolism; 2000 May; 49(5):567-73. PubMed ID: 10831164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.